Neural Analytics Receives $10 Million Contract from the United States Army to Develop Portable Point of Injury Device to Assess Combat-Related Traumatic Brain Injury

LOS ANGELES--()--Neural Analytics, Inc., a medical device company developing and commercializing technology to measure, diagnose and track brain health, today announced that the Department of Defense (DoD) has awarded the company a $10 million contract to develop and supply a portable, point of injury device for assessing combat-related traumatic brain injury (TBI). The contract was awarded by the U.S. Army Medical Research and Materiel Command.

Neural Analytics will partner with the DoD to develop its Lucid System within the next 18 months to measure and monitor physiological parameters relevant to moderate-severe TBI and to operate in prolonged field care scenarios. Battelle, headquartered in Columbus, OH, will provide technical and advanced engineering expertise enabling ruggedization and miniaturization suitable to meet military requirements. The system is expected to operate as a single, portable unit with minimal required training and maintenance.

“We are honored to continue our partnership with the U.S. Army to further advance point of care injury management of brain health,” said Leo Petrossian, Ph.D., Co-Founder and Chief Executive Officer of Neural Analytics. “We believe our technology will be the first of its kind targeted for a military environment. This work will also significantly impact civilian versions of the technology allowing for further advancement of our Lucid System in the pre-hospital or EMS setting.”

Following completion of the point of injury brain health assessment device, Neural Analytics plans to continue to supply the system to the DoD and commercialize the technology into its civilian brain health platforms.

More than 370,000 military service members have sustained TBIs over the last 16 years.1 Combat-related TBI is a significant and common injury of military conflict. It is often associated with multiple casualty scenarios, further complicating triage and treatment decisions.

This work is supported by the U.S. Army Medical Research and Materiel Command under Contract No. W81XWH-17-C-0245.

The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official DoD position, policy or decision unless so designated by other documentation.

Source:

1Defense Medical Surveillance System and Theater Medical Data Store provided by the Armed Forces Health Surveillance Branch Prepared by the Defense and Veterans Brain Injury Center. Accessed on September 28, 2017: https://dvbic.dcoe.mil/files/tbi-numbers/worldwide-totals-2000-2017_aug-10-2017_v1.0_2017-09-21.pdf

About Neural Analytics Inc.

Neural Analytics was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, TBI and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their devices are designed to be portable, autonomous, reliable and produce precise and objective physiological measurements for medical responder monitoring of neural disorders.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, energy and environmental industries. For more information, visit www.battelle.org.

Contacts

Neural Analytics Inc.
Kevin Lai, +1-949-241-9379
Marketing Manager

Contacts

Neural Analytics Inc.
Kevin Lai, +1-949-241-9379
Marketing Manager